8-Bromo-6-chloro-3-methylimidazo[1,2-a]pyrazine, 95%, 1g

2,5,8,11,14,17,20,23,26,29,32,35,38-Tridecaoxahentetracontan-41-oic acid, 95%, 5g

(5-Phenyl-4 H -[1,2,4]triazol-3-ylsulfanyl)-acetic acid, 250mg

(5-Methoxy-2-methylphenyl)methanamine hydrochloride, 95%, 100mg

2-Methoxy-5-nitro-nicotinic acid, 95.0%, 250mg

3,4-Dichlorobenzoyl chloride, 98.0%, 25g

2-({1-[(5-methyl-1,2-oxazol-3-yl)carbamoyl]ethyl}sulfanyl)acetic acid, 97%, 250mg

2-Isopropylthioxanthone, 98.0%, 25g

5-(3,4-Dimethoxy-phenyl)-isoxazole-3-carboxylic acid, 95.0%, 500mg

8-Fluoroquinazoline-2,4(1H,3H)-dione, 95.0%, 5g

2-(Trifluoromethoxy)benzaldehyde>95.0%(GC)5g

tert-Butyl (2-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-oxoethyl)carbamate, 98%, 250mg

Soporte de catalizador de óxido de circonio(IV) 3 mm 500 g